Helen Thomas

Helen Thomas has a diverse work experience spanning over 17 years. Helen is currently working as the Director Clinical Study Team Lead at Pfizer since 2023. Before that, they worked as an MSc student at the University of Oxford, where they completed their degree from October 2021 to September 2023. Helen also held roles as a Contract Senior Clinical Project Manager at Freeline from May to August 2023, and as a Partner at tranScrip from November 2021 to May 2022. Prior to that, they worked as a Consultant Program Manager at CEPI from March 2020 to November 2021. Helen has also worked at Roche, Chugai Pharma Europe, Chugai, Quintiles, and Abbott Diabetes Care in various clinical operations and project management roles.

Helen Thomas holds a Master's degree in Clinical Research from the University of Oxford, which they obtained from 2021 to 2023. Helen also has a Bachelor's degree in Human Sciences with Human Genetics from UCL, acquired between 1998 and 2001. In addition, they are currently pursuing an MSc in Experimental and Translational Therapeutics at the University of Oxford. Helen has an additional certification in PMP from PMI, although the specific obtained month and year is unspecified.